Department of Medical Microbiology, Antwerp University Hospital, Antwerp, Belgium; Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium.
Vaccine & Infectious Disease Institute (VAXINFECTIO), University of Antwerp, Antwerp, Belgium; Department of Primary and Interdisciplinary Care (ELIZA), University of Antwerp, Antwerp, Belgium; Department of Epidemiology and Social Medicine (ESOC), University of Antwerp, Antwerp, Belgium.
Clin Microbiol Infect. 2018 Nov;24(11):1158-1163. doi: 10.1016/j.cmi.2018.02.004. Epub 2018 Feb 12.
To describe the role of bacteria (including bacterial resistance), viruses (including those recently described) and mixed bacterial-viral infections in adults presenting to primary care with lower respiratory tract infection (LRTI).
In all, 3104 adults with LRTI were enrolled, of whom 141 (4.5%) had community-acquired pneumonia (CAP), and 2985 matched controls in a prospective study in 16 primary care networks in Europe, and followed patients up at 28-35 days. We detected Streptococcus pneumoniae and Haemophilus influenzae and assessed susceptibility, atypical bacteria and viruses.
A potential pathogen was detected in 1844 (59%) (in 350 (11%) bacterial pathogens only, in 1190 (38%) viral pathogens only, and in 304 (10%) both bacterial and viral pathogens). The most common bacterial pathogens isolated were S. pneumoniae (5.5% overall, 9.2% in CAP patients) and H. influenzae (5.4% overall, 14.2% in CAP patients). Less than 1% of S. pneumoniae were highly resistant to penicillin and 12.6% of H. influenzae were β-lactamase positive. The most common viral pathogens detected were human rhinovirus (20.1%), influenza viruses (9.9%), and human coronavirus (7.4%). Influenza virus, human parainfluenza viruses and human respiratory syncytial virus as well as human rhinovirus, human coronavirus and human metapneumovirus were detected significantly more frequently in LRTI patients than in controls.
A bacterial pathogen is identified in approximately one in five adult patients with LRTI in primary care, and a viral pathogen in just under half, with mixed infections in one in ten. Penicillin-resistant pneumococci and β-lactamase-producing H. influenzae are uncommon. These new findings support a restrictive approach to antibiotic prescribing for LRTI and the use of first-line, narrow-spectrum agents in primary care.
描述细菌(包括耐药菌)、病毒(包括最近描述的病毒)以及细菌-病毒混合感染在以下呼吸道感染(LRTI)就诊于初级保健的成人中的作用。
共纳入 3104 例 LRTI 成人患者,其中 141 例(4.5%)为社区获得性肺炎(CAP),在欧洲 16 个初级保健网络的前瞻性研究中,对 2985 例匹配对照进行了研究,并在 28-35 天对患者进行了随访。我们检测了肺炎链球菌和流感嗜血杆菌,并评估了其药敏性、非典型细菌和病毒。
在 1844 例(59%)患者中检测到潜在病原体(仅 350 例(11%)为细菌病原体,1190 例(38%)为病毒病原体,304 例(10%)为细菌和病毒病原体)。分离的最常见细菌病原体是肺炎链球菌(总体 5.5%,CAP 患者中 9.2%)和流感嗜血杆菌(总体 5.4%,CAP 患者中 14.2%)。不到 1%的肺炎链球菌对青霉素高度耐药,12.6%的流感嗜血杆菌β-内酰胺酶阳性。检测到的最常见病毒病原体是人鼻病毒(20.1%)、流感病毒(9.9%)和人冠状病毒(7.4%)。流感病毒、人副流感病毒和人呼吸道合胞病毒以及人鼻病毒、人冠状病毒和人偏肺病毒在 LRTI 患者中比在对照组中更频繁地被检测到。
在初级保健中,约五分之一的成人 LRTI 患者可确定细菌病原体,近一半的患者可确定病毒病原体,十分之一的患者存在混合感染。青霉素耐药肺炎链球菌和产β-内酰胺酶流感嗜血杆菌不常见。这些新发现支持对 LRTI 采用限制抗生素处方的方法,并支持在初级保健中使用一线窄谱药物。